Melanopsin-Driven Pupil Response and Light Exposure in Non-seasonal Major Depressive Disorder

被引:17
|
作者
Feigl, Beatrix [1 ,2 ,3 ]
Ojha, Govinda [1 ,2 ]
Hides, Leanne [4 ]
Zele, Andrew J. [1 ,5 ]
机构
[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Med Retina & Visual Sci Labs, Brisbane, Qld, Australia
[2] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[3] Queensland Eye Inst, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia
[5] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia
来源
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
基金
澳大利亚研究理事会;
关键词
pupil; melanopsin; light exposure; depression; MDD = major depressive disorder; RETINAL GANGLION-CELLS; PHOTOTRANSDUCTION; ARCHITECTURE; PROJECTIONS; REFLEX; MOOD;
D O I
10.3389/fneur.2018.00764
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Melanopsin-expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) signal non-imaging forming effects of environmental light for circadian phoentrainment, the pupil light reflex, and mood regulation. In seasonal affective disorder, ipRGC dysfunction is thought to cause abberant transmission of the external illumination for photoentrainment. It is not known if patients with non-seasonal depression have abnormal melanospin mediated signaling and/or irregular environmental light exposure. Methods: Twenty-one adults who live in a sub-tropical region, including eight patients with non-seasonal depression and thirteen age-matched healthy controls were recruited. The Mini International Neuropsychiatry Interview diagnosed the presence of a major depressive disorder. Light exposure was determined using actigraphy over a 2 week period. The melanopsin mediated post-illumination pupil response (PIPR) and outer retinal inputs to ipRGCs (transient pupil response and maximum pupil constriction amplitude) were measured in response to 1 s, short and long wavelength light with high and low melanopsin excitation. Results: The mean daylight exposure as a function of clock hours and total light exposure duration (mins) to illumination levels commonly recommended for depression therapy were not significantly different between groups. Out of 84 pupil measurements (42 each in the depression and control groups), the melanopsin-mediated PIPR amplitude, transient pupil response, and pupil constriction amplitude were not significantly different between groups. Conclusions: This report provides initial evidence of normal melanopsin function and environmental light exposures in patients with pre-dominately mid and moderate non-seasonal depression in a subtropical location in the southern hemisphere.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder
    Fanelli, G.
    Benedetti, F.
    Kasper, S.
    Zohar, J.
    Souery, D.
    Montgomery, S.
    Albani, D.
    Forloni, G.
    Ferentinos, P.
    Rujescu, D.
    Mendlewicz, J.
    Serretti, A.
    Fabbri, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S99 - S100
  • [42] Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder
    Fanelli, Giuseppe
    Benedetti, Francesco
    Kasper, Siegfried
    Zohar, Joseph
    Souery, Daniel
    Montgomery, Stuart
    Albani, Diego
    Forloni, Gianluigi
    Ferentinos, Panagiotis
    Rujescu, Dan
    Mendlewicz, Julien
    Serretti, Alessandro
    Fabbri, Chiara
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 108
  • [43] Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I/II Trial
    Geoffroy, Pierre Alexis
    El Abbassi, El Mountacer Billah
    Maruani, Julia
    Etain, Bruno
    Lejoyeux, Michel
    Amad, Ali
    Courtet, Philippe
    Dubertret, Caroline
    Gorwood, Philip
    Vaiva, Guillaume
    Bellivier, Frank
    Chevret, Sylvie
    PSYCHIATRY INVESTIGATION, 2018, 15 (12) : 1188 - 1202
  • [44] DATA-DRIVEN LEARNING ANALYSIS IDENTIFIES GENDER DIFFERENCES IN METABOLIC TREATMENT RESPONSE OF CITALOPRAM/ESCITALOPRAM IN MAJOR DEPRESSIVE DISORDER
    Athreya, A. P.
    Neavin, D.
    Bobo, W. V.
    Frye, M. A.
    Skime, M.
    Kaddurah-Daouk, R.
    Rush, A. J.
    Matson, W.
    Iyer, R. K.
    Wang, L.
    Weinshilboum, R. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S18 - S18
  • [45] MINDFULNESS-BASED STRESS REDUCTION FOR POSTTRAUMATIC STRESS DISORDER, COFFEE CONSUMPTION AND MORTALITY, PHYTOESTROGENS FOR MENOPAUSE, LIGHT THERAPY FOR NON-SEASONAL DEPRESSION, ELECTROACUPUNCTURE FOR LABOR PAIN
    Mukherji, Atreyi
    Glickman-Simon, Richard
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2016, 12 (03) : 210 - 214
  • [46] Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT
    Kato, Masaki
    Takekita, Yoshiteru
    Koshikawa, Yosuke
    Sakai, Shiho
    Bandou, Hiroki
    Nishida, Keiichiro
    Sunada, Naotaka
    Onohara, Ai
    Hatashita, Yoshiyuki
    Serretti, Alessandro
    Kinoshita, Toshihiko
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 89 : 97 - 104
  • [47] Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder
    Fatt, Cherise R. Chin
    Cooper, Crystal M.
    Jha, Manish K.
    Abu Minhajuddin
    Rush, A. John
    Trombello, Joseph M.
    Fava, Maurizio
    McInnis, Melvin
    Weissman, Myrna
    Trivedi, Madhukar H.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 282 : 602 - 610
  • [48] HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Fanelli, Giuseppe
    Kasper, Siegfried
    Kautzky, Alexander
    Zohar, Joseph
    Souery, Daniel
    Montgomery, Stuart
    Albani, Diego
    Ferentinos, Panagiotis
    Rujescu, Dan
    Mendlewicz, Julien
    Serretti, Alessandro
    Fabbri, Chiara
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S207 - S207
  • [49] EVALUATION OF FACTORS AFFECTING TREATMENT RESPONSE AND RISK FACTORS FOR PATIENTS DIAGNOSED WITH NON-PSYCHOTIC MAJOR DEPRESSIVE DISORDER: A LITERATURE REVIEW
    Greene, N.
    Greene, M.
    VALUE IN HEALTH, 2013, 16 (07) : A693 - A694
  • [50] Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIs
    Dodd, Seetal
    Berk, Michael
    EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (01) : 17 - 17